Overview

Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management

Status:
Recruiting
Trial end date:
2022-03-15
Target enrollment:
Participant gender:
Summary
The study will evaluate the eradication rate and tolerability of modified LOAD regimens (three antibiotics and a proton pump inhibitor (lansoprazole)) for management of HP infection in treatment-naive patients as well as patients who failed previous therapies.
Phase:
Phase 4
Details
Lead Sponsor:
National Liver Institute, Egypt
Collaborator:
Future pharmaceutical industries